Altimmune (ALT) Receivables - Other (2010 - 2026)
Altimmune's (ALT) quarterly Receivables - Other came in at $1.4 million in Q1 2026, up 250.0% year-on-year from $400000.0 in Q1 2025, and up 27.27% on a QoQ basis from $1.1 million in Q4 2025.
Altimmune (ALT) Receivables - Other (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 12 years of Receivables - Other data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Receivables - Other rose 250.0% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 250.0% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 175.0% from the prior year.
- Receivables - Other for Q1 2026 stood at $1.4 million, up from $1.1 million in the prior quarter.
- Over the last five years, Receivables - Other for ALT reached as high as $1.4 million in Q1 2026 and fell as low as $100000.0 in Q4 2023.
- Historically, Receivables - Other has averaged $544444.4 across 4 years, with a median of $400000.0 in 2024.
- Across the five-year window, Receivables - Other jumped 300.0% in 2024 and surged 100.0% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $100000.0 in 2023, then soared by 300.0% to $400000.0 in 2024, then surged by 175.0% to $1.1 million in 2025, then increased by 27.27% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Mar 31, 2017 | 798,855.00 |
| Mar 31, 2017 | 798,855.00 |